These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.

View All HCPCS Sections

• J9297

  Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg

• J9298

  Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg

• J9299

  Injection, nivolumab, 1 mg

• J9300

  Injection, gemtuzumab ozogamicin, 5 mg

• J9301

  Injection, obinutuzumab, 10 mg

• J9302

  Injection, ofatumumab, 10 mg

• J9303

  Injection, panitumumab, 10 mg

• J9304

  Injection, pemetrexed (pemfexy), 10 mg

• J9305

  Injection, pemetrexed, not otherwise specified, 10 mg

• J9306

  Injection, pertuzumab, 1 mg

• J9307

  Injection, pralatrexate, 1 mg

• J9308

  Injection, ramucirumab, 5 mg

• J9309

  Injection, polatuzumab vedotin-piiq, 1 mg

• J9310

  Injection, rituximab, 100 mg

• J9311

  Injection, rituximab 10 mg and hyaluronidase

• J9312

  Injection, rituximab, 10 mg

• J9313

  Injection, moxetumomab pasudotox-tdfk, 0.01 mg

• J9314

  Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg

• J9315

  Injection, romidepsin, 1 mg

• J9316

  Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg

• J9317

  Injection, sacituzumab govitecan-hziy, 2.5 mg

• J9318

  Injection, romidepsin, non-lyophilized, 0.1 mg

• J9319

  Injection, romidepsin, lyophilized, 0.1 mg

• J9320

  Injection, streptozocin, 1 gram

• J9321

  Injection, epcoritamab-bysp, 0.16 mg

• J9322

  Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg

• J9323

  Injection, pemetrexed ditromethamine, 10 mg

• J9324

  Injection, pemetrexed (pemrydi rtu), 10 mg

• J9325

  Injection, talimogene laherparepvec, per 1 million plaque forming units

• J9326

  Injection, telisotuzumab vedotin-tllv, 1 mg

• J9328

  Injection, temozolomide, 1 mg

• J9329

  Injection, tislelizumab-jsgr, 1mg

• J9330

  Injection, temsirolimus, 1 mg

• J9331

  Injection, sirolimus protein-bound particles, 1 mg

• J9332

  Injection, efgartigimod alfa-fcab, 2mg

• J9333

  Injection, rozanolixizumab-noli, 1 mg

• J9334

  Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc

• J9340

  Injection, thiotepa, 15 mg

• J9341

  Injection, thiotepa (tepylute), 1 mg

• J9342

  Injection, thiotepa, not otherwise specified, 1 mg

• J9345

  Injection, retifanlimab-dlwr, 1 mg

• J9347

  Injection, tremelimumab-actl, 1 mg

• J9348

  Injection, naxitamab-gqgk, 1 mg

• J9349

  Injection, tafasitamab-cxix, 2 mg

• J9350

  Injection, mosunetuzumab-axgb, 1 mg

• J9351

  Injection, topotecan, 0.1 mg

• J9352

  Injection, trabectedin, 0.1 mg

• J9353

  Injection, margetuximab-cmkb, 5 mg

• J9354

  Injection, ado-trastuzumab emtansine, 1 mg

• J9355

  Injection, trastuzumab, excludes biosimilar, 10 mg

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/4/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.